SK287152B6 - Použitie dezoxypeganínu na liečenie klinickej depresie - Google Patents

Použitie dezoxypeganínu na liečenie klinickej depresie Download PDF

Info

Publication number
SK287152B6
SK287152B6 SK258-2004A SK2582004A SK287152B6 SK 287152 B6 SK287152 B6 SK 287152B6 SK 2582004 A SK2582004 A SK 2582004A SK 287152 B6 SK287152 B6 SK 287152B6
Authority
SK
Slovakia
Prior art keywords
depression
deoxypeganine
use according
medicament preparation
abuse
Prior art date
Application number
SK258-2004A
Other languages
English (en)
Slovak (sk)
Other versions
SK2582004A3 (en
Inventor
Joachim Moormann
Hermann Mucke
Original Assignee
Hf Arzneimittelforschung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforschung Gmbh filed Critical Hf Arzneimittelforschung Gmbh
Publication of SK2582004A3 publication Critical patent/SK2582004A3/sk
Publication of SK287152B6 publication Critical patent/SK287152B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SK258-2004A 2001-12-21 2002-12-14 Použitie dezoxypeganínu na liečenie klinickej depresie SK287152B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10163667A DE10163667B4 (de) 2001-12-21 2001-12-21 Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
PCT/EP2002/014274 WO2003053445A1 (de) 2001-12-21 2002-12-14 Verwendung von desoxypeganin zur behandlung der klinischen depression

Publications (2)

Publication Number Publication Date
SK2582004A3 SK2582004A3 (en) 2004-12-01
SK287152B6 true SK287152B6 (sk) 2010-01-07

Family

ID=7710660

Family Applications (1)

Application Number Title Priority Date Filing Date
SK258-2004A SK287152B6 (sk) 2001-12-21 2002-12-14 Použitie dezoxypeganínu na liečenie klinickej depresie

Country Status (29)

Country Link
US (1) US20050009813A1 (cs)
EP (1) EP1461042B1 (cs)
JP (1) JP2005513105A (cs)
KR (1) KR100614504B1 (cs)
CN (1) CN1283253C (cs)
AR (1) AR037967A1 (cs)
AT (1) ATE404203T1 (cs)
AU (1) AU2002363874B2 (cs)
BR (1) BR0215306A (cs)
CA (1) CA2471338C (cs)
CZ (1) CZ301210B6 (cs)
DE (2) DE10163667B4 (cs)
DK (1) DK1461042T3 (cs)
EA (1) EA006896B1 (cs)
ES (1) ES2312657T3 (cs)
HU (1) HUP0402298A3 (cs)
IL (2) IL162509A0 (cs)
MX (1) MXPA04006125A (cs)
MY (1) MY138088A (cs)
NO (1) NO326446B1 (cs)
NZ (1) NZ533249A (cs)
PL (1) PL370315A1 (cs)
PT (1) PT1461042E (cs)
SI (1) SI1461042T1 (cs)
SK (1) SK287152B6 (cs)
TW (1) TWI241189B (cs)
UA (1) UA76254C2 (cs)
WO (1) WO2003053445A1 (cs)
ZA (1) ZA200404053B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
EP1578422B1 (en) * 2002-12-20 2007-04-11 NicoNovum AB A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
FR2865650B1 (fr) * 2004-01-30 2008-06-13 Biocortech Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil
JP5000932B2 (ja) * 2005-06-21 2012-08-15 日東電工株式会社 ニコチン含有経皮吸収製剤
WO2007104573A2 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
CN101433565B (zh) * 2008-11-26 2013-06-05 上海中医药大学 骆驼蓬属种子总生物碱提取物和它们的制备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit

Also Published As

Publication number Publication date
CA2471338A1 (en) 2003-07-03
ZA200404053B (en) 2004-10-12
EA200400751A1 (ru) 2004-12-30
NO20042476L (no) 2004-06-14
ES2312657T3 (es) 2009-03-01
HUP0402298A2 (hu) 2005-02-28
JP2005513105A (ja) 2005-05-12
TWI241189B (en) 2005-10-11
EP1461042B1 (de) 2008-08-13
SK2582004A3 (en) 2004-12-01
AR037967A1 (es) 2004-12-22
IL162509A (en) 2010-06-16
CZ301210B6 (cs) 2009-12-09
PL370315A1 (en) 2005-05-16
HUP0402298A3 (en) 2011-03-28
BR0215306A (pt) 2004-12-21
KR20040068327A (ko) 2004-07-30
DE10163667B4 (de) 2006-10-26
DE10163667A1 (de) 2003-07-10
DK1461042T3 (da) 2008-12-01
AU2002363874A1 (en) 2003-07-09
AU2002363874B2 (en) 2007-12-13
CA2471338C (en) 2009-02-24
IL162509A0 (en) 2005-11-20
UA76254C2 (en) 2006-07-17
HK1066742A1 (zh) 2005-04-01
PT1461042E (pt) 2008-11-03
SI1461042T1 (sl) 2009-02-28
CN1283253C (zh) 2006-11-08
MXPA04006125A (es) 2005-05-16
EP1461042A1 (de) 2004-09-29
KR100614504B1 (ko) 2006-08-22
MY138088A (en) 2009-04-30
NO326446B1 (no) 2008-12-08
NZ533249A (en) 2007-05-31
TW200301124A (en) 2003-07-01
ATE404203T1 (de) 2008-08-15
DE50212649D1 (de) 2008-09-25
CZ2004739A3 (cs) 2004-12-15
WO2003053445A8 (de) 2004-07-01
CN1604781A (zh) 2005-04-06
US20050009813A1 (en) 2005-01-13
EA006896B1 (ru) 2006-04-28
WO2003053445A1 (de) 2003-07-03

Similar Documents

Publication Publication Date Title
TWI776407B (zh) 激動劑形成之調配物及使用其之方法
AU2003284005B2 (en) Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
JP2009543767A (ja) フリバンセリンとカフェインとを含む組成物、その調製方法及び薬剤としての使用
AU2018302248B2 (en) Compositions for treating stress-related disorders
US20130237526A1 (en) Pharmaceutical composition
SK15652003A3 (sk) Kombinácia účinných látok na medikamentóznu terapiu návykových alebo omamných prostriedkov
SK284937B6 (sk) Použitie prokineticky účinného antiemetika a tramadolu na výrobu liečiva na liečenie migrény
SK287152B6 (sk) Použitie dezoxypeganínu na liečenie klinickej depresie
US20090291939A1 (en) Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking
MXPA04006124A (es) Cabeza de cilindro.
US6335372B1 (en) Treatment of obsessive compulsive disorder
MXPA04006126A (es) Acero para herramientas de arranque de viruta.
CZ355998A3 (cs) Pyridil a pyrimidylpiperaziny pro léčení poruch způsobených odejmutím drogy
CA2338326A1 (en) Use of moclobemide and metabolites for treating and preventing substance abuse
JP2007528891A (ja) 複合鎮痛剤医薬組成物
WO2002056869A2 (en) Method for treating sexual disorders
HK1066742B (en) Use of desoxypeganine for treating clinical depression
NZ718978A (en) Novel treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
NZ718978B2 (en) Novel treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20111214